Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma of Anal Canal”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Testing effectiveness (Phase 2)Ended earlyNCT01382745
What this trial is testing

Nimotuzumab With Radiotherapy in the Treatment of Anal Canal Cancers

Who this might be right for
Squamous Cell Carcinoma of Anal Canal
Dr. Te Vuong 1
Not applicableStudy completedNCT05201105
What this trial is testing

Tumor Recurrence After Abdominal-perineal Amputation in Squamous Cell Carcinoma of the Anus

Who this might be right for
Squamous Cell Carcinoma of the Anal Canal
Fondation Hôpital Saint-Joseph 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Large-scale testing (Phase 3)Active Not RecruitingNCT04444921
What this trial is testing

EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients

Who this might be right for
Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaMetastatic Anal Squamous Cell Carcinoma+4 more
National Cancer Institute (NCI) 205
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Large-scale testing (Phase 3)Study completedNCT04472429
What this trial is testing

Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).

Who this might be right for
Squamous Cell Carcinoma of the Anal Canal
Incyte Corporation 308
Not applicableStudy completedNCT02379039
What this trial is testing

Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer

Who this might be right for
Squamous CarcinomaHead and Neck CancerAnal Cancer+3 more
Umeå University 118
Not applicableAvailableNCT06910137
What this trial is testing

An Early Access Program Guideline to Provide Access to Retifanlimab (INCMGA00012) Together With Carboplatin and Paclitaxel for Squamous Carcinoma of the Anal Canal (SCAC)

Who this might be right for
Squamous Cell Carcinoma of the Anal Canal
Incyte Corporation
Testing effectiveness (Phase 2)WithdrawnNCT04499352
What this trial is testing

Test BI 754091 Alone or in Combination With BI 836880 in People Who Have Advanced Anal Cancer

Who this might be right for
Anal Canal Squamous Cell Carcinoma
Boehringer Ingelheim
Testing effectiveness (Phase 2)Study completedNCT03690921
What this trial is testing

Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial

Who this might be right for
Anal Canal Squamous Cell CarcinomaStage I Anal Cancer AJCC v8Stage II Anal Cancer AJCC v8+6 more
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT00093379
What this trial is testing

Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer

Who this might be right for
Anal Cancer
M.D. Anderson Cancer Center 20
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Early research (Phase 1)Study completedNCT04580485
What this trial is testing

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

Who this might be right for
Ovarian CancerBladder CancerNon Small Cell Lung Cancer+8 more
Incyte Corporation 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT04166318
What this trial is testing

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

Who this might be right for
Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Canal Squamous Cell Carcinoma+3 more
ECOG-ACRIN Cancer Research Group 252
Testing effectiveness (Phase 2)Study completedNCT02399813
What this trial is testing

Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal

Who this might be right for
Anal CancerRectal Cancer
Advaxis, Inc. 36
Testing effectiveness (Phase 2)Looking for participantsNCT06640283
What this trial is testing

Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes

Who this might be right for
HPV-Related CarcinomaUterine Cervical CancerAnal Canal Cancer+2 more
Instituto do Cancer do Estado de São Paulo 150
Large-scale testing (Phase 3)Active Not RecruitingNCT03233711
What this trial is testing

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

Who this might be right for
Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Margin Squamous Cell Carcinoma+2 more
National Cancer Institute (NCI) 344
Testing effectiveness (Phase 2)Study completedNCT05060471
What this trial is testing

PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA Patients

Who this might be right for
Anal Canal CancerAnal Squamous Cell CarcinomaAnal Cancer+3 more
Sun Yat-sen University 25
Testing effectiveness (Phase 2)UnknownNCT03870607
What this trial is testing

Prebiotics and Probiotics During Definitive Treatment With Chemotherapy-radiotherapy SCC of the Anal Canal (BISQUIT)

Who this might be right for
Anal Cancer Squamous Cell
AC Camargo Cancer Center 75
Load More Results